Daniel F. Veber

1 ta ish

GlaxoSmithKline (United States)

1. Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

   Daniel F. Veber, Stephen R. Johnson, Hung‐Yuan Cheng +3

   Maqola20025 iqtibos

   ABIABI:AkademIndex/2026.other.050870